About Algenex
Algenex is a company based in Madrid (Spain) founded in 2005. Algenex has raised $13.28 million across 2 funding rounds from investors including Columbus Venture Partners and Vita Advisory. Algenex offers products and services including Top-Bac® and CrisBio®. Algenex operates in a competitive market with competitors including Core Biogenesis, Qkine, Future Fields, Protera and Icon Genetics, among others.
- Headquarter Madrid, Spain
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Algenex Sl
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$13.28 M (USD)
in 2 rounds
-
Latest Funding Round
$8.75 M (USD), Series B
Sep 08, 2020
-
Investors
Columbus Venture Partners
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Algenex
Algenex offers a comprehensive portfolio of products and services, including Top-Bac® and CrisBio®.
Boosts recombinant biologics production using Baculovirus systems.
Enables scalable protein production for health and diagnostics applications.
Funding Insights of Algenex
Algenex has successfully raised a total of $13.28M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $8.75 million completed in September 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Algenex
Algenex has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Columbus Venture Partners and Vita Advisory.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Columbus Venture Partners is focused on biotechnology investment funds.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Algenex
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Algenex
Investment portfolio details for Algenex
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Algenex
Detailed financials for Algenex
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Algenex Comparisons
Peer comparison for Algenex
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Algenex
Algenex operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Core Biogenesis, Qkine, Future Fields, Protera and Icon Genetics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
UBaaS platform for plant-based recombinant protein bioproduction is offered.
|
|
| Locked | Locked | Locked |
Animal-free growth factors are developed for life science applications.
|
|
| Locked | Locked | Locked |
Serum-free bioactive growth factors and recombinant proteins are biomanufactured.
|
|
| Locked | Locked | Locked |
Protein-based enzyme technologies are developed using deep learning algorithms.
|
|
| Locked | Locked | Locked |
Biopharmaceuticals and proteins are developed using green plants as hosts.
|
Detailed competitors of Algenex
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Algenex
Complete news archive for Algenex
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Algenex
Algenex was founded in 2005 and raised its 1st funding round 14 years after it was founded.
Algenex is headquartered in Madrid, Spain. It is registered at Madrid, Madrid, Spain.
Algenex is a funded company, having raised a total of $13.28M across 2 funding rounds to date.
Algenex was founded in 2005 in Madrid, Spain, within the biotechnology sector. Recombinant biologics for animal and human health are produced through a baculovirus expression vector system. Platforms such as Top-Bac, which enhances protein quality via a proprietary cassette, and IBES, utilizing insect larvae as bioreactors, are employed. Resulting proteins support vaccines, diagnostic reagents, and therapeutic molecules.
Algenex's top competitors include Future Fields, Qkine and Oxford Expression Technologies.
Algenex offers Top-Bac® and CrisBio®.
Algenex has 2 investors. Key investors include Columbus Venture Partners, and Vita Advisory.